Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.

Tobias Welponer* (Erstautor/-in), Daniela Weber (Co-Autor/-in), Lisa Trattner (Co-Autor/-in), Birgit Tockner (Co-Autor/-in), Sepideh Aminzadeh-Gohari (Co-Autor/-in), Victoria Leb-Reichl (Co-Autor/-in), Anna Kaufmann (Co-Autor/-in), Roland Zauner (Co-Autor/-in), Monika Wimmer (Co-Autor/-in), Verena Wally (Co-Autor/-in), Thomas Felder (Co-Autor/-in), Dirk Strunk (Co-Autor/-in), Ulrich Koller (Co-Autor/-in), Johann Bauer (Co-Autor/-in), Barbara Kofler (Co-Autor/-in), Christina Guttmann-Gruber (Letztautor/-in), J Piñon Hofbauer* (Letztautor/-in)

*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in FachzeitschriftOriginalarbeit (Zeitschrift)Begutachtung

4 Quellenangaben (Web of Science)
OriginalspracheEnglisch
FachzeitschriftJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
DOIs
PublikationsstatusVeröffentlicht - 2023

Dieses zitieren